MedTrace Logo

1H Magnetic Resonance Spectroscopy in Migraine Patients

NCT04220606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2020-01-07

No results posted yet for this study

Summary

To investigate the glutaminergic system in the onset of migraine-like attacks.

Conditions

  • Migraine Disorders
  • Migraine Without Aura
  • Headache Disorders, Primary
  • Headache Disorders
  • Brain Diseases
  • Central Nervous System Diseases
  • Nervous System Diseases

Interventions

DRUG

Glyceryl trinitrate (I.V. infusion 0.5 µg/kg/min over 20 min)

Sponsors & Collaborators

  • Netherlands Organisation for Scientific Research

    collaborator OTHER_GOV

  • European Commission

    collaborator OTHER

  • Leiden University Medical Center

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04220606 on ClinicalTrials.gov